You are not currently logged in.
Access JSTOR through your library or other institution:
Nosocomial Methicillin‐Resistant and Methicillin‐Susceptible Staphylococcus aureus Primary Bacteremia: At What Costs?
Murray A. Abramson , MD and Daniel J. Sexton , MD
Infection Control and Hospital Epidemiology
Vol. 20, No. 6 (June 1999), pp. 408-411
Published by: Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Stable URL: http://www.jstor.org/stable/10.1086/501641
Page Count: 4
You can always find the topics here!Topics: Staphylococcus aureus, Hospital costs, Bacteremia, Infections, Length of stay, Direct costs, Cost control, Hospitalization, Teaching hospitals, Endocarditis
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
OBJECTIVE. To determine the attributable hospital stay and costs for nosocomial methicillin‐sensitive Staphylococcus aureus (MSSA) and methicillin‐resistant S aureus (MRSA) primary bloodstream infections (BSIs). DESIGN. Pairwise‐matched (1:1) nested case‐control study. SETTING. University‐based tertiary‐care medical center. PATIENTS. Patients admitted between December 1993 and March 1995 were eligible. Cases were defined as patients with a primary nosocomial S aureus BSI; controls were selected according to a priori matching criteria. MEASUREMENTS. Length of hospital stay and total and variable direct costs of hospitalization. RESULTS. The median hospital stay attributable to primary nosocomial MSSA BSI was 4 days, compared with 12 days for MRSA (P=.023). Attributable median total cost for MSSA primary nosocomial BSIs was $9,661 versus $27,083 for MRSA nosocomial infections (P=.043). CONCLUSION. Nosocomial primary BSI due to S aureus significantly prolongs the hospital stay. Primary nosocomial BSIs due to MRSA result in an approximate threefold increase in direct cost, compared with those due to MSSA.
© 1999 by The Society for Healthcare Epidemiology of America. All rights reserved.